Insider buying last 90 days
No open-market insider purchases were filed for BCS in the last 90 days.
From Form 4 filings, dated to when each was filed.
Barclays shares moved this week against a backdrop of regulatory and legal filings rather than core operating news: a Form 424B2 for Autocallable Leveraged Buffered Notes linked to the iShares Semiconductor ETF, a Form 8.3 disclosure on SEGRO PLC positions, a Holding(s) in Company notice tied to a 7.11% voting stake in Mobico Group PLC, and a report that Rosen Law Firm continues to investigate potential securities claims tied to prior disclosures. Separately, Barclays disclosed it is stepping up client reviews to track flood exposure amid regulatory pressure from the Bank of England, while a Group Chief Risk Officer share acquisition under the SAYE scheme was also noted. Commentary also surfaced questioning whether Barclays shares represent a FTSE 100 bargain following mixed third-quarter results.
The stock closed at $23.70, up 5.8% on the day, but remains below both its 50-day average of $24.30 and 200-day average of $24.82, with the 50-day below the 200-day. The three-month return stands at -15.9%, while the one-year return is 10.2%. The GekkoIndex reads 59.7, placing it in the Neutral zone. Gekko Fair Value sits at $26.44, putting the current price 10.4% below that mark.
The next earnings date falls on 9 February 2027, 96 days out, beyond a typical 20-trading-day hold. No insider, Congress, or unusual options activity appears in the respective 90-day and 30-day windows. Seasonality data show the next 20 trading days have averaged a 4.6% gain over 5 years, rising in 4 of them. Analyst consensus from 2 firms carries a $29.42 target, implying 24.1% upside.
Written by AI from the Nov 4, 2026 close and checked automatically against the figures on this page.
Barclays scores 3 supportive, 1 mixed and 1 headwind across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive1 mixed1 headwind
Below 50 and 200-day
Close $23.70 is below the 50-day ($24.30) and 200-day ($24.82) averages, and the 50-day is below the 200-day.
See the chart59.7, Neutral
Reading 59.7 is in the Neutral zone.
See the GekkoIndex10.4% below
Price is 10.4% below Gekko Fair Value (more than 5% below).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 96 days
Next report Feb 9, 2027, 96 days away — outside a typical 20-trading-day hold.
See earnings+4.6% on average
From this point in the calendar, the next 20 trading days averaged +4.6% over 5 years, rising in 4 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Barclays closed at $23.70 on Nov 4, 2026, +10.2% over the past year, inside a 52-week range of $19.84 to $28.69.
Use the left and right arrow keys to read daily values.
Put BCS on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Barclays supplies a wide array of banking and finance services to individuals and businesses spread across the UK, Europe, the Americas, Africa, the Middle East, and Asia. Customers can access everyday banking products such as deposit and savings accounts, home loans, credit cards, and personal borrowing, together with services covering corporate banking, investment banking, wealth management, and asset management. It also handles trading in securities and the issuance of credit cards.
Operationally, the company is divided into distinct segments: Barclays UK, Barclays UK Corporate Bank, Barclays Private Bank and Wealth Management, Barclays Investment Bank, and Barclays US Consumer Bank. Through these divisions it reaches everyday retail customers, corporate accounts, private and wealth management clients, and consumer banking customers in the United States, covering a mix of personal and institutional financial needs.
The bank dates back to 1690 and keeps its head office in London, United Kingdom. It once carried the name Barclays Bank public limited company before being renamed Barclays PLC in early 1985. Its stock trades on the NASDAQ under the ticker BCS.
Barclays’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 59.7, in the Neutral zone, down 5.8 points over five sessions.
Down 5.8 points over five sessions, from the Accumulation zone.
Reading for Nov 4, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 28 | +0.4% | +10.1% | ||
| Accumulation | 104 | +1.7% | +4.1% | ||
| Neutral (current zone) | 487 | +0.6% | +2.7% | ||
| Distribution | 31 | +0.1% | +3.3% | ||
| Selling | 0 | Not available | |||
Average BCS share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.0% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
Barclays trades 10.4% below Gekko Fair Value of $26.44, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what Barclays shares are worth, recalculated every trading day.
$26.44
Gekko Fair Value, Nov 3, 2026
10.4% Undervalued
At the end of Aug 2026 the price was 9.0% below the estimate.
No open-market insider purchases were filed for Barclays, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for BCS in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in BCS were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
1of the funds Gekko tracks holds BCS.
Barclays reports on Feb 9, 2027, before the open (96 days away), and beat the EPS estimate in 7 of its last 8 reports.
Feb 9, 2027
Expected before the open, 96 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Oct 22, 2026 | $0.66 est $0.67 | $9.86B est $10.10B | −3.8% |
| Jul 28, 2026 | $0.90 est $0.89 | $11.08B est $10.78B | −8.8% |
| Apr 28, 2026 | $0.76 est $0.75 | $11.02B est $10.88B | −0.4% |
| Feb 10, 2026 | $0.46 est $0.42 | $9.68B est $9.42B | −2.1% |
| Oct 22, 2025 | $0.56 est $0.54 | $9.64B est $9.26B | +5.7% |
| Jul 29, 2025 | $0.62 est $0.50 | $25.11B est $9.38B | +2.3% |
| Apr 30, 2025 | $0.65 est $0.61 | $9.95B est $9.31B | −1.9% |
| Feb 13, 2025 | $0.21 est $0.19 | $7.13B est $9.17B | −3.3% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Barclays is $29.42, +24.1% from the last close, from 2 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 2 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Oct 23 | Berenberg Bank | $33.50 | +41.4% |
| Sep 1 | Bank of America Securities | — | — |
| Sep 1 | Bank of America Securities | — | — |
| Aug 14 | Berenberg Bank | $33.50 | +41.4% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Nov 4, Barclays averaged +4.6% across the last 5 years, rising in 4 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +3.7% | 4 of 5 |
| Next 10 trading days | +3.8% | 4 of 5 |
| Next 15 trading days | +3.0% | 4 of 5 |
| Next 20 trading days | +4.6% | 4 of 5 |
| Next 30 trading days | +5.8% | 4 of 5 |
For scale, BCS’s typical 20-trading-day move in either direction is about 6.5%.
Barclays’s market cap is $79.79B, with a P/E ratio of 8.3 and revenue of $28.46B over the last twelve months.
Coverage of Barclays this week reads neutral: 5 positive, 11 neutral and 2 negative headlines.
Barclays’s market cap is $79.79B at the Nov 4, 2026 close of $23.70, with 3.32B shares outstanding. The shares trade on a P/E ratio of 8.3.
The consensus analyst 12-month price target for Barclays is $29.42, +24.1% from the last close. Of the 2 firms that rated the stock in the last 90 days, 1 rate it a buy, 1 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Barclays is undervalued: the Nov 4, 2026 close of $23.70 is 10.4% below Gekko Fair Value of $26.44. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Barclays is expected to report on Feb 9, 2027, before the market opens (96 days away). Analysts expect earnings of $0.48 per share on revenue of $9.89B. Barclays beat the earnings estimate in 7 of its last 8 reports, moving 3.5% on average across the report.
Barclays’s 52-week high is $28.69 and its 52-week low is $19.84; it closed at $23.70 on Nov 4, 2026, +10.2% over the past year.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (fair value, earnings risk and seasonality), 1 as mixed (gekkoindex) and 1 as a headwind (trend). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,461 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.